Neogollin Tablet 10 mg (Nisergoline)

Adult dose

* 5 mg, 10 mg Adults: Administer 5 ∼ 10 mg of nicergoline orally 3 times daily before meals. Adjust the dose as appropriate according to symptoms. * 30 mg Adults: Administer 30 mg of nicergoline orally once daily before a meal. If the desired effect is not achieved at this dose, it may be increased to 60 mg. The dose may be reduced after symptoms improve. For patients with impaired renal function (serum creatinine >175 µmol/L) (2 mg/dL), administer a reduced dose.

This medication should not be used in certain patients. For example, patients allergic to this drug or ergot alkaloids should not be administered. Additionally, patients with acute myocardial infarction or acute hemorrhage, those taking sympathomimetic agents, patients with significantly slow heart rates, patients who have not completed hemostasis after intracranial bleeding, and patients with orthostatic dysregulation should not use this medication. Patients with mild bradycardia or compromised renal function should use this medication cautiously. While taking this drug, gastrointestinal symptoms such as loss of appetite, diarrhea, constipation, nausea, and vomiting may occur, and rarely liver function tests may show increased levels. Dizziness, orthostatic dysregulation, blood pressure changes, drowsiness, headaches, and insomnia may also occur rarely, so caution is needed. Allergic reactions such as skin rashes or itching may occur rarely. Taking this drug with other antihypertensive agents may lead to excessively low blood pressure, hence blood pressure should be monitored frequently. Patients with a history of hyperuricemia or gout should be cautious as this medication may affect uric acid metabolism. After taking this drug, caution is needed when driving or operating machinery. This medication is metabolized in the liver by specific enzymes, so interactions may occur when taken with other related drugs. Women who are pregnant or may become pregnant should use this medication cautiously as its safety has not been established, under the judgment of their physician. In breastfeeding cases, this medication may be secreted in breast milk, so it is advisable to avoid its use or to discontinue breastfeeding if possible. Elderly patients may have diminished physical function, so caution is needed in adjusting the dosage. The safety in children has not been confirmed, so its use is not recommended. In cases of overdose, blood pressure may temporarily drop, so blood pressure changes should be closely monitored and necessary measures should be taken. This medication should be kept out of the reach of children and should not be stored in any other container apart from its original.

• Anorexia
• diarrhea
• constipation
• nausea
• vomiting
• intermittent upper abdominal pain
• cramps
• thirst
• ALT elevation
• AST elevation

This medication should be stored in a sealed container to protect it from air and moisture, and it is safe to store at room temperature between 1 degree and 30 degrees Celsius. Maintaining the proper temperature and container conditions helps preserve the medication's effectiveness over time.

Appearance

White round film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle